Your browser doesn't support javascript.
loading
Simultaneous inhibition of ATM, ATR, and DNA-PK causes synergistic lethality.
Kato, Takamitsu A; Maeda, Junko; Watanabe, Hiroya; Kawamura, Shinji; Wilson, Paul F.
Afiliação
  • Kato TA; Department of Environmental & Radiological Health Sciences, Colorado State University, Fort Collins, CO, 80523, USA. Electronic address: Takamitsu.Kato@Colostate.edu.
  • Maeda J; Department of Environmental & Radiological Health Sciences, Colorado State University, Fort Collins, CO, 80523, USA.
  • Watanabe H; Department of Environmental & Radiological Health Sciences, Colorado State University, Fort Collins, CO, 80523, USA; Faculty of Fukuoka Medical Technology, Teikyo University, Fukuoka, 836-0037, Japan.
  • Kawamura S; Faculty of Fukuoka Medical Technology, Teikyo University, Fukuoka, 836-0037, Japan.
  • Wilson PF; Biological Sciences Division, Pacific Northwest National Laboratory, Richland, WA, 99352, USA.
Biochem Biophys Res Commun ; 738: 150517, 2024 Aug 08.
Article em En | MEDLINE | ID: mdl-39146620
ABSTRACT
Here we report that simultaneous inhibition of the three primary DNA damage recognition PI3 kinase-like kinases (PIKKs) -ATM, ATR, and DNA-PK- induces severe combinatorial synthetic lethality in mammalian cells. Utilizing Chinese hamster cell lines CHO and V79 and their respective PIKK mutants, we evaluated effects of inhibiting these three kinases on cell viability, DNA damage response, and chromosomal integrity. Our results demonstrate that while single or dual kinase inhibition increased cytotoxicity, inhibition of all three PIKKs results in significantly higher synergistic lethality, chromosomal aberrations, and DNA double-strand break (DSB) induction as calculated by their synergy scores. These findings suggest that the overlapping redundancy of ATM, ATR, and DNA-PK functions is critical for cell survival, and their combined inhibition greatly disrupts DNA damage signaling and repair processes, leading to cell death. This study provides insights into the potential of multi-targeted DDR kinase inhibition as an effective anticancer strategy, necessitating further research to elucidate underlying mechanisms and therapeutic applications.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article